Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-transplant cyclophosphamide to prevent complications in female donor pregnancy-exposed stem cell transplant
IRCT20140818018842N44Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cyclophosphamide in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), sponsored by Tehran University of Medical Sciences. Started Jan 2025; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT20140818018842N44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140818018842N44.